|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 401/06 | |
| A61K 31/454 | |||
| A61P 5/06 |
| (11) | Number of the document | 1768976 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05766869.1 |
| Date of filing the European patent application | 2005-06-22 | |
| (97) | Date of publication of the European application | 2007-04-04 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2005/022408 |
| Date | 2005-06-22 |
| (87) | Number | WO 2006/016995 |
| Date | 2006-02-16 |
| (30) | Number | Date | Country code |
| 583757 P | 2004-06-29 | US |
| (72) |
LORIMER, Keith, US
PINES, Seemon, H., US
PAUL, Bernhard, US
LITTER, Benjamin, US
|
| (73) |
Helsinn Healthcare S.A.,
Via Pian Scairolo, 9, 6912 Lugano / Pazzallo,
CH
|
| (54) | CRYSTAL FORMS OF (3R)-1-(2-METHYLALANYL-D-TRYPTOPHYL)-3-(PHENYLMETHYL)-3-PIPERIDINECARBOXYLIC ACID 1,2,2-TRIMETHYLHYDRAZIDE |
| CRYSTAL FORMS OF (3R)-1-(2-METHYLALANYL-D-TRYPTOPHYL)-3-(PHENYLMETHYL)-3-PIPERIDINECARBOXYLIC ACID 1,2,2-TRIMETHYLHYDRAZIDE |